Korean Market
EXCH
MYUNGIN PHARM
★

MYUNGIN PHARM Files Corporate Governance Report: Dividend Expansion and Value-Up Plan Established, Continuous Governance Improvement

 
PERI
MYUNGIN PHARM
★★★

Myungin Pharm: Strong Q1 2026 Results, CNS Market Leader, Promising Pipeline

 
EXCH
MYUNGIN PHARM
★★

Cash Dividend of KRW 1,500 Per Share Announced (Total KRW 21.9 Billion)

 
EXCH
MYUNGIN PHARM
★

Myungin Pharm AGM: Election of Inside Directors Lee and Cha, Articles Amendment

 
EXCH
MYUNGIN PHARM
★

Myungin Pharm's major shareholder donates 1.06M shares, stake falls to 43.62%

 
OWNR
MYUNGIN PHARM
★

Filing of Ownership Report by Executives and Major Shareholders

 
OWNR
MYUNGIN PHARM
★

Executives and Major Shareholders Report Filed, No Changes

 
OWNR
MYUNGIN PHARM
★

Submission of Securities Ownership Report by Executives and Major Shareholders (No Content)

 
OWNR
MYUNGIN PHARM
★

Filing of Large Shareholding Report (No Specific Changes)